Clinical Trial Detail

NCT ID NCT03694249
Title Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vanderbilt-Ingram Cancer Center
Indications

gastroesophageal junction adenocarcinoma

lung small cell carcinoma

esophagus adenocarcinoma

triple-receptor negative breast cancer

esophagus squamous cell carcinoma

lung non-small cell carcinoma

gastroesophageal cancer

stomach cancer

pancreatic adenocarcinoma

Therapies

Ifetroban sodium

Age Groups: senior adult

No variant requirements are available.